🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 105 of 114

  1. bimekizumab

    Lacuna Pharma Pty Ltd

    Psoriatic Arthritis

    phase 3 small molecule active

    1 trial

  2. bimekizumab

    Lacuna Pharma Pty Ltd

    Hidradenitis Suppurativa

    phase 3 small molecule active

    1 trial

  3. bimekizumab

    Lacuna Pharma Pty Ltd

    Axial Spondyloarthritis

    phase 3 small molecule active

    1 trial

  4. bimekizumab

    Lacuna Pharma Pty Ltd

    Active juvenile idiopathic arthritis subtypes enthesitis-related arthritis (including juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritis

    phase 3 small molecule active

    1 trial

  5. bimekizumab, Skyrizi 150 mg solution for injection in pre-filled syringe, Placebo matching test and comparator. 0.9% sodium chloride solution for injection (unauthorized).

    Lacuna Pharma Pty Ltd

    Psoriatic arthritis

    phase 3 small molecule active

    1 trial

  6. biphasic insulin aspart

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    1 trial

  7. bivalent enterovirus vaccine (Vero cell), inactivated

    Sinovac Research and Development Co.,

    Hand, Foot, and Mouth Disease（HFMD)

    phase 3 mab active

    1 trial

  8. blisibimod

    Santhera Pharmaceuticals (Deutschland) GmbH

    Systemic Lupus Erythematosus

    phase 3 small molecule completed

    1 trial

  9. bococizumab (PF-04950615)

    Pfizer

    Cardiovascular Disease

    phase 3 small molecule terminated

    1 trial

  10. botulinum toxin Type A

    Allergan Pharmaceuticals International Limited

    Pediatrics

    phase 3 mab completed

    4 trials

  11. brentuximab vedotin

    Takeda

    Hodgkin Lymphoma

    phase 3 small molecule completed

    3 trials

  12. brigatinib

    Takeda

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  13. brivaracetam, -, -, brivaracetam, -, brivaracetam, Placebo matching < brivaracetam oral solution> and without active substance

    Lacuna Pharma Pty Ltd

    Childhood Absence Epilepsy Juvenile Absence Epilepsy

    phase 3 small molecule active

    1 trial

  14. brivaracetam, brivaracetam, brivaracetam, brivaracetam

    Lacuna Pharma Pty Ltd

    Childhood Absence Epilepsy, Juvenile Absence Epilepsy

    phase 3 small molecule active

    1 trial

  15. budesonide/formoterol 'as needed' + budesonide placebo bid

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  16. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Pain, Postoperative

    phase 3 small molecule active

    1 trial

  17. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Knee Osteoarthritis

    phase 3 small molecule completed

    1 trial

  18. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Pain

    phase 3 small molecule completed

    2 trials

  19. cART(TDF/AZT+3TC+LPV/r)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute HIV Infection

    phase 3 small molecule active

    1 trial

  20. cagrilintide semaglutide, Placebo + Placebo, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide

    NovoThirteen

    Obesity

    phase 3 small molecule active

    1 trial

  21. cagrilintide semaglutide, Placebo + Placebo, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide

    NovoThirteen

    Cardiovascular disease

    phase 3 small molecule active

    1 trial

  22. cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, METFORMIN , INSULIN DEGLUDEC , INSULIN (HUMAN) , INSULIN GLARGINE , cagrilintide semaglutide, INSULIN DETEMIR , Placebo + Placebo

    NovoThirteen

    Type 2 diabetes

    phase 3 small molecule active

    1 trial

  23. cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, Placebo + Placebo, cagrilintide semaglutide

    NovoThirteen

    Overweight and obesity and type 2 diabetes

    phase 3 small molecule active

    1 trial

  24. cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, Placebo + Placebo

    NovoThirteen

    Type 2 diabetes

    phase 3 small molecule active

    1 trial

  25. cagrilintide, Placebo, cagrilintide, cagrilintide, cagrilintide

    NovoThirteen

    Overweight and obesity

    phase 3 small molecule active

    1 trial

  26. cagrilintide, cagrilintide, cagrilintide, cagrilintide, Placebo

    NovoThirteen

    Overweight and obesity

    phase 3 small molecule active

    1 trial

  27. camizestrant, Arimidex® 1 mg Filmtabletten, IBRANCE 75 mg hard capsules, Placebo to match camizestrant, Placebo to match Arimidex, LEUPRORELIN ACETATE, IBRANCE 125 mg hard capsules, IBRANCE 75 mg film-coated tablets, IBRANCE 100 mg hard capsules, IBRANCE 75 mg hard capsules, IBRANCE 100 mg hard capsules, IBRANCE 125 mg film-coated tablets, IBRANCE 100 mg film-coated tablets, IBRANCE 125 mg hard capsules, IBRANCE 100 mg hard capsules, Camizestrant, IBRANCE 125 mg hard capsules, IBRANCE 75 mg hard capsules, G

    AstraZeneca AB

    Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

    phase 3 small molecule active

    1 trial

  28. canakinumab

    Novartis Pharmaceuticals

    Non-small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  29. candesartan

    Takeda

    Type 1 Diabetes

    phase 3 small molecule completed

    1 trial

  30. candesartan

    Takeda

    Type 2 Diabetes

    phase 3 small molecule completed

    1 trial

  31. candesartan cilexetil

    Takeda

    Type 1 Diabetes

    phase 3 small molecule completed

    1 trial

  32. casirivimab+imdevimab

    Regeneron UK Limited

    Immunocompromised

    phase 3 small molecule terminated

    1 trial

  33. casirivimab+imdevimab combination therapy

    Regeneron UK Limited

    COVID-19

    phase 3 small molecule terminated

    1 trial

  34. cemiplimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    3 trials

  35. centrally blinded product containing all the same manufactured ingredients and excipients as the DM199 formulation, except for the active pharmaceutical ingredient (API).

    DiaMedica Therapeutics

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  36. cetuximab + cisplatin + vinorelbine

    Merck KGaA, Darmstadt, Germany

    Non Small Cell Lung Cancer (NSCLC)

    phase 3 small molecule completed

    1 trial

  37. chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Limited Stage Small Cell Lung Cancer

    phase 3 other active

    1 trial

  38. ciclesonide

    Takeda

    Asthma

    phase 3 small molecule completed

    2 trials

  39. ciclesonide (XRP1526)

    Takeda

    Respiratory Tract Diseases

    phase 3 small molecule completed

    1 trial

  40. cilostazol

    Hospital Authority, Hong Kong

    Coronary Artery Stenosis

    phase 3 small molecule active

    1 trial

  41. cisplatin

    Pari Pharma GmbH

    Lung Cancer

    phase 3 small molecule completed

    1 trial

  42. cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Cavity

    phase 3 small molecule completed

    1 trial

  43. cisplatin

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 small molecule completed

    1 trial

  44. cisplatin i.p.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Carcinoma, Ovarian

    phase 3 small molecule active

    1 trial

  45. cleminorexton

    Centessa Pharmaceuticals plc

    Narcolepsy Type 1

    phase 3 small molecule active

    1 trial

  46. clopidogrel and aspirin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atherosclerosis

    phase 3 small molecule active

    1 trial

  47. cognitive-behavioral withdrawal regulation strategies

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    phase 3 other active

    1 trial

  48. colchicine

    Ultragenyx UK Limited

    Liver Cirrhosis, Biliary

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.